Detalhe da pesquisa
1.
SARS-CoV-2 Variants, South Sudan, January-March 2021.
Emerg Infect Dis
; 27(12): 3133-3136, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34708685
2.
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201.
Emerg Infect Dis
; 27(6): 1598-1606, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34013872
3.
Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
J Autoimmun
; 112: 102462, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561150
4.
Willingness to pay for National Health Insurance Fund among public servants in Juba City, South Sudan: a contingent evaluation.
Int J Equity Health
; 16(1): 158, 2017 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28854972
5.
Transmissibility and severity of COVID-19 in a humanitarian setting: First few X investigation of cases and contacts in Juba, South Sudan, 2020.
Influenza Other Respir Viruses
; 17(11): e13200, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019703
6.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study.
medRxiv
; 2021 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758900